ClinicalTrials.gg
RecruitingNCT06025864Updated Sep 6, 2023

Protocol to Support Breastfeeding for Postpartum Women and Mothers of Babies With Congenital Heart Disease

An interventional study of Breastfeeding in Breastfeeding and Congenital Heart Disease, sponsored by Instituto de Cardiologia do Rio Grande do Sul. Recruiting at 1 site in Brazil. Open to participants aged 1 Day to 3 Days. Per ClinicalTrials.gov, last updated 2023-09-06.

Sponsored by Instituto de Cardiologia do Rio Grande do Sul · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 11 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 1 month after the study started (first participant enrolled Jul 2022, registered Aug 2023).
  • Started Jul 2022; still recruiting 4 years 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
1 Day to 3 Days
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Breast Feeding with a site in Brazil — 1 open to participants now, 1 under way, none of them phase 3. Breast Feeding · Brazil.

Planned enrollment
8th of 14
72 · median 87
Started
2022
with 1 other
No phase
11 of 18
1 open now
Registered
16th of 18
by date
Lead sponsor
1 of 18
Instituto de Cardiologia do Rio Grande do Sul

Among the 18 studies in Breast Feeding with a site in Brazil, this one is the 8th largest by planned enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2022, is one of 11 with no phase, and was the 16th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

1 of the 18 studies in Breast Feeding with a site in Brazil is open now.

A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 1 Day to 3 Days · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Breast Feeding with a site in Brazil, or all of them as a file.
02

Study summary

To evaluate the effect of applying a hybrid protocol (face-to-face and via call center) of breastfeeding assistance and guidance on the duration of breast milk supply to babies with congenital heart disease for 6 months.

Read the detailed description

The objective of this randomized, multicenter clinical trial is to evaluate the effect of applying a hybrid protocol (face-to-face and telemarketing) of assistance and guidance on breastfeeding and duration of breast milk supply for infants with congenital heart disease in the first 6 months of life. Recruitment of infants diagnosed with congenital heart disease occurs within the first 72 hours of life, being followed up for 6 months.

Initially, the mothers in the control group, as well as the mothers in the intervention group, receive a booklet with guidelines on breastfeeding, a standardized measuring cup for milk collections and a breastfeeding booklet.

In addition, mothers in the intervention group receive monthly videos with guidance on breastfeeding, monthly consultations with a breastfeeding consultant and a support group via whatsapp with the researcher and scientific initiation student until the baby is 6 months old.

03

Conditions studied

  • Breastfeeding
  • Congenital Heart Disease

Keywords

  • breast milk
  • congenital heart desease
  • nutritional status
  • 6 months
  • call center
04

Who can participate

Ages eligible
1 Day to 3 Days
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants diagnosed with congenital heart disease,
  • The parents must have a cell phone enabled to receive video calls.

Exclusion criteria

Exclusion Criteria:

  • Mothers carriers of the (HIV),
  • Mothers users of medications without medical indication to initiate or maintain breastfeeding.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Intervention Group

    Support for breastfeeding and depletion of breast milk throughout the 6 months. Free and professional support through monthly consultations and videos on the subject.

    Other: Breastfeeding

  • No intervention
    Control Group

    All mothers were followed up for 6 months and received a breastfeeding support booklet virtually, through a cell phone application. The booklet provides basic information about breastfeeding and possible complications. The recruited mothers also received a notebook to record the date, duration, volume and frequency of breastfeeding and/or milk collections, and the use of alternative routes such as a bottle, cup or enteral nutrition. At the initial visit, all mothers were given a standard measuring cup to measure the volume of milk used up in the household each day. In addition, all mothers received a call 7 days after delivery to apply the Portuguese version of the Breastfeeding Self-Efficacy Survey - Short Form: BSES-SF. This questionnaire was reapplied after 90 days.

Interventions

  • OtherBreastfeeding

    Over the 6 months of the intervention, 1 video per month was sent, a total of 6 videos, via the mobile application, with guidance on breastfeeding: the importance of maternal hydration; myths and truths about the mother's diet; practical guidance on breastfeeding; baby's gastric capacity; picking up and positioning the baby during breastfeeding and storing milk for the return to work. There were also 1 call per month, with an average duration of 15 minutes, with a breastfeeding consultant nutritionist, aiming to solve doubts and difficulties that month. In order to provide complete assistance, virtual groups were created via the WhatsApp application, with a nutritionist and a health academic to solve doubts, provide emotional support and exchange information when necessary. According to the region or municipality of origin of the mother-baby dyad, when necessary, this study provided the loan of a breast pump during the follow-up period or 6 months.

06

What researchers measure

Primary outcomes

  1. Breast milk supply rate during the baby's 6-month period

    Increase milk supply directly from the mother's breast or through pumps for use in alternative routes.

    Time frame: Up to 6 months

Secondary outcomes

  1. Compare the time of breastfeeding

    Compare the time of offering the breast between the control group and the intervention group

    Time frame: Up to 6 months

  2. Breastfeeding self-efficacy before and during the intervention

    The breastfeeding self-efficacy questionnaire in a reduced format (BSES-SF) will be applied in two moments during the infant's 6 months of life, and the effectiveness of the interventions can be observed. The score can vary from 1 to 70, where higher results reflect greater self-efficacy in breastfeeding.

    Time frame: Up to 6 months

  3. Assessment of the nutritional status of infants at 6 months of age using the growth curves of the World Health Organization and classified according to the Z score

    Assess the nutritional status of infants at 6 months of age through weight and height. These data will be placed on the nutritional assessment curves of the World Health Organization (WHO) and classified using the Z score. Afterwards, the results between the intervention and control groups will be compared.

    Time frame: Up to 6 months

07

Study locations

1 of 1 sites recruiting
  • Juliana Caprini
    Caxias do Sul, Rio Grande Do Sul 95080560, Brazil
    Recruiting
    • Juliana Caprini, Esp · Contactjuli_caprini@yahoo.com · (54)992044907
    • Fernanda Lucchese-Lobato, PHD · Principal investigator
    • Juliana Caprini, Esp · Sub investigator
08

References and documents

Publications

  • Carlsen EM, Kyhnaeb A, Renault KM, Cortes D, Michaelsen KF, Pryds O. Telephone-based support prolongs breastfeeding duration in obese women: a randomized trial. Am J Clin Nutr. 2013 Nov;98(5):1226-32. doi: 10.3945/ajcn.113.059600. Epub 2013 Sep 4. PubMed 24004897 ↗
  • Dodt RC, Joventino ES, Aquino PS, Almeida PC, Ximenes LB. An experimental study of an educational intervention to promote maternal self-efficacy in breastfeeding. Rev Lat Am Enfermagem. 2015 Jul-Aug;23(4):725-32. doi: 10.1590/0104-1169.0295.2609. PubMed 26444176 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2022 (actual). Primary completion is estimated for Dec 2023, 17 months after the start.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 17 months is above that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2023
First posted
Sep 6, 2023
StartActual
Jul 1, 2022
Primary completionEst.
Dec 20, 2023
CompletionEst.
Feb 20, 2024
Last update
Sep 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06025864
Lead sponsor
Instituto de Cardiologia do Rio Grande do Sul
Collaborators
Irmandade Santa Casa de Misericórdia de Porto Alegre
Responsible party
Fernanda Lucchese (Principal Investigator, Instituto de Cardiologia do Rio Grande do Sul) — Principal investigator
First posted
Sep 6, 2023
Start date
Jul 1, 2022
Primary completion
Dec 20, 2023 (estimated)
Completion
Feb 20, 2024 (estimated)
Last update
Sep 6, 2023

Study contacts

Juliana Caprini, Esp
Contact
juli_caprini@yahoo.com
(54)992044907
Fernanda Lucchese-Lobato, PHD
principal investigator · Instituto de Cardiologia de Porto Alegre

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion